The virology and developments toward control of human enterovirus 71

Critical Reviews in Microbiology

Volumn 37, Issue 4, 2011, Pages 313-327

  Yi, Lina ^a   Lu, Jing ^a   Kung, Hsiang Fu ^a,b   He, Ming Liang ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Antiviral; EV71; Virology

Indexed keywords

CD209 ANTIGEN; ENTEROVIRUS 71 VACCINE; GENOMIC RNA; GLYCAN; GLYCOLIPID; P SELECTIN GLYCOPROTEIN LIGAND 1; PLECONARIL; PROTEIN VP1; SCAVENGER RECEPTOR B; SCAVENGER RECEPTOR BII; SIALIC ACID; SIALOMUCIN; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS RNA; VIRUS VACCINE;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ASEPTIC MENINGITIS; AUSTRALIA; AUTONOMIC DYSFUNCTION; BACTERIAL GENOME; BULGARIA; CELL DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CHINA; COXSACKIE VIRUS B; COXSACKIE VIRUS INFECTION; ENDEMIC DISEASE; ENDOCYTOSIS; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; EPIDEMIC; ERYTHEMA; FEVER; FLACCID PARALYSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HALF LIFE TIME; HAND FOOT AND MOUTH DISEASE; HERPANGINA; HUMAN; JAPAN; LUNG EDEMA; LUNG HEMORRHAGE; LYMPHADENOPATHY; MOLECULAR EPIDEMIOLOGY; MOUTH DISEASE; NETHERLANDS; NEUROLOGIC DISEASE; NONHUMAN; PAPULE; PAPULOVESICULAR RASH; PATHOGENESIS; PHYLOGENY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; RNA TRANSPORT; SKIN DISEASE; SORE THROAT; TAIWAN; TONGUE DISEASE; UNITED STATES; VIET NAM; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS ETIOLOGY; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSCRIPTION;

COXSACKIEVIRUS INFECTIONS; DISEASE OUTBREAKS; ENTEROVIRUS A, HUMAN; HUMANS;

ENTEROVIRUS; HUMAN ENTEROVIRUS 71; PICORNAVIRIDAE;

EID: 80053624332     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2011.580723     Document Type: Review

References (169)

1. Abdel-Rahman SM, Kearns Gl. 1999. Single oral dose escalation pharmacokinetics of pleconaril (VP 63843) capsules in adults. J Clin Pharmacol. 39:613-8. (Pubitemid 30629041)
2. Abubakar S, Chee HY, Al-Kobaisi MF, Xiaoshan J, Chua KB, Lam SK. 1999. Identifcation of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in Malaysia. Virus Res. 61:1-9. (Pubitemid 29276867)
3. Abubakar S, Sam IC, Yusof J, Lim MK, Misbah S, Matrahim N, Hooi PS. 2009. Enterovirus 71 outbreak, Brunei. Emerg Infect Dis. 15:79-82.
4. Alexander Jr JP, Baden L, Pallansch MA, Anderson LJ. 1994. Enterovirus 71 infections and neurologic disease-United States, 1977-1991. J Infect Dis. 169:905-8.
5. Arita M, Nagata N, Iwata N, Ami Y, Suzaki Y, Mizuta K, Iwasaki T, Sata T, Wakita T, Shimizu H. 2007. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol. 81:9386-95. (Pubitemid 47311481)
6. Arita M, Wakita T, Shimizu H. 2008. Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. J Gen Virol. 89:2518-30.
7. Basavappa R, Syed R, Flore O, Icenogle JP, Filman DJ, Hogle JM. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci. 3:1651-69. (Pubitemid 24356589)
8. Belov GA, Ehrenfeld E. 2007. Involvement of cellular membrane trafc proteins in poliovirus replication. Cell Cycle. 6:36-8. (Pubitemid 46173877)
9. Belsham GJ, Sonenberg N. 1996. RNA-protein interactions in regulation of picornavirus RNA translation. Microbiol Rev. 60:499-511. (Pubitemid 26303476)
10. Berasain C, Hevia H, Fernandez-Irigoyen J, Larrea E, Caballeria J, Mato JM, Prieto J, Corrales FJ, Garcia-Trevijano ER, Avila MA. 2004. Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Biochim Biophys Acta. 1690;276-84. (Pubitemid 39423623)
11. Blomberg J, Lycke E, Ahlfors K, Johnsson T, Wolontis S, Von Zeipel G. 1974. Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet. 2:112.
12. Brisac C, Teoule F, Autret A, Pelletier I, Colbere-Garapin F, Brenner C, Lemaire C, Blondel B. 2010. Calcium fux between the endoplasmic reticulum and mitochondrion contributes to poliovirus-induced apoptosis. J Virol. 84:12226-35.
13. Brown BA, Kilpatrick DR, Oberste, MS, Pallansch MA. 2000. Serotype-specifc identifcation of enterovirus 71 by PCR. J Clin Virol. 16:107-12.
14. Brown BA, Oberste MS, Alexander Jr JP, Kennett Ml, Pallansch MA. 1999. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J Virol. 73:9969-75.
15. Brown BA, Pallansch MA. 1995. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 39:195-205. (Pubitemid 26054785)
16. Cardosa MJ, Perera D, Brown BA, Cheon D, Chan HM, Chan KP, Cho H, Mcminn P. 2003. Molecular epidemiology of human enterovirus 71 strains and recent outbreaks in the Asia-Pacifc region: comparative analysis of the VP1 and VP4 genes. Emerg Infect Dis. 9:461-8. (Pubitemid 37070413)
17. Chan KP, Goh KT, Chong CY, Teo ES, Lau G, Ling AE. 2003. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg Infect Dis. 9:78-85. (Pubitemid 36110205)
18. Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, Ho KK, Han LL, Pallansch MA, Suleiman AB, Jegathesan M, Anderson LJ. 2000. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 31:678-83. (Pubitemid 32295486)
19. Chang JS, Wang KC, CHIANG LC. 2008. Sheng-Ma-Ge-Gen-Tang inhibited Enterovirus 71 infection in human foreskin fbroblast cell line. J Ethnopharmacol. 119:104-8.
20. Chang LY, Huang LM, Gau SS, Wu YY, Hsia SH, Fan TY, Lin KL, Huang YC, Lu CY, Lin TY. 2007. Neurodevelopment and cognition in children after enterovirus 71 infection. N Engl J Med. 356:1226-34. (Pubitemid 46465598)
21. Chang LY, King CC, Hsu KH, Ning HC, Tsao KC, Li CC, Huang YC, Shih SR, Chiou ST, Chen PY, Chang HJ, Lin T Y. 2002. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 109:e88.
22. Chang LY, Lin TY, Hsu KH, Huang YC, Lin KL, Hsueh C, Shih SR, Ning HC, Hwang MS, Wang HS, Lee CY. 1999. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 354:1682-6. (Pubitemid 29533058)
23. Chatproedprai S, Teanboonlers A, Korkong S, Tongmee C, Wananukul S, Poovorawan Y., Clinical,and molecular characterization of hand-foot-and-mouth disease in Tailand, 2008-2009. Jpn J Infect Dis. 63:229-33.
24. Chen CY, Chang YC, Huang CC, Lui CC, LEE KW, Huang SC. 2001. Acute faccid paralysis in infants and young children with enterovirus 71 infection: MR imaging fndings and clinical correlates. AJNR Am J Neuroradiol. 22:200-5.
25. Chen HF, Chang MH, Chiang BL, Jeng ST. 2006a. Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine. 24:2944-51.
26. Chen HL, Huang JY, CHU TW, TSAI TC, Hung CM, Lin CC, Liu FC, Wang LC, Chen YJ, Lin MF, Chen CM. 2008a. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine. 26:2882-9.
27. Chen LC, Shyu HW, Chen SH, Lei HY, Yu CK, Yeh TM. 2006b. Enterovirus 71 infection induces Fas ligand expression and apoptosis of Jurkat cells. J Med Virol. 78:780-6.
28. Chen TC, Chang HY, Lin PF, Chern JH, Hsu JT, Chang CY, Shih SR. 2009. Novel antiviral agent DTriP-22 targets RNA-dependent RNA polymerase of enterovirus 71. Antimicrob Agents Chemother. 53:2740-7.
29. Chen TC, Liu SC, Huang PN, Chang HY, Chern JH, Shih SR. 2008b. Antiviral activity of pyridyl imidazolidinones against enterovirus 71 variants. J Biomed Sci. 15:291-300.
30. Chern JH, Lee CC, Chang CS, Lee YC, Tai CL, Lin YT, Shia KS, Lee CY, Shih SR. 2004. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones. Bioorg Med Chem Lett. 14:5051-6.
31. Chiang LC, Ng LT, Cheng PW, Chiang W, Lin CC. 2005. Antiviral activities of extracts and selected pure constituents of Ocimum basilicum. Clin Exp Pharmacol Physiol. 32:811-6. (Pubitemid 43906523)
32. Chiu CH, Chu C, He CC, Lin TY. 2006. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 8:1671-8. (Pubitemid 44128870)
33. Choi HJ, Lim CH, Song JH, Baek SH, Kwon DH. 2009. Antiviral activity of raoulic acid from Raoulia australis against Picornaviruses. Phytomedicine. 16:35-9.
34. Chonmaitree T, Menegus MA, Schervish-Swierkosz EM, Schwalenstocker E. 1981. Enterovirus 71 infection: report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics. 67:489-93. (Pubitemid 11061319)
35. Chua KB, Chua BH, Lee CS, Chem YK, Ismail N, Kiyu A, Kumarasamy V. 2007. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays J Pathol. 29:69-78.
36. Chumakov M, Voroshilova M, Shindarov L, Lavrova I, Gracheva L, Koroleva G, Vasilenko S, Brodvarova I, Nikolova M, Gyurova S, Gacheva M, Mitov G, Ninov N, Tsylka E, Robinson I, Frolova M, Bashkirtsev V, Martiyanova L, Rodin V. 1979. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch Virol. 60:329-40. (Pubitemid 9221445)
37. Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC. 2008. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine. 26:1855-62.
38. Clarke P, Kitchin N, Souverbie F. 2001. A randomised comparison of two inactivated hepatitis A vaccines, Avaxim and Vaqta, given as a booster to subjects primed with Avaxim. Vaccine. 19:4429-33. (Pubitemid 32718666)
39. Clemens MJ, Bushell M, Morley SJ. 1998. Degradation of eukaryotic polypeptide chain initiation factor (eIF) 4G in response to induction of apoptosis in human lymphoma cell lines. Oncogene. 17:2921-31. (Pubitemid 29010062)
40. Da Silva EE, Winkler MT, Pallansch MA. 1996. Role of enterovirus 71 in acute faccid paralysis after the eradication of poliovirus in Brazil. Emerg Infect Dis. 2:231-3. (Pubitemid 126444992)
41. Dales S. 1962. An electron microscope study of the early association between two mammalian viruses and their hosts. J Cell Biol. 13:303-22.
42. Dong C, Wang J, Liu L, Zhao H, Shi H, Zhang Y, Jiang L, Li Q. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum Vaccin, 6.
43. Eskelinen EL, Tanaka Y, Saftig P. 2003. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol. 13:137-45. (Pubitemid 36293786)
44. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. 1982. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem. 257:14806-10. (Pubitemid 13159573)
45. Foo DG, Alonso S, Phoon MC, Ramachandran NP, Chow VT, Poh CL. 2007. Identifcation of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides. Virus Res. 125:61-8. (Pubitemid 46413387)
46. Fujimoto T, Yoshida S, Munemura T, Taniguchi K, Shinohara M, Nishio O, Chikahira M, Okabe N. 2008. Detection and quantifcation of enterovirus 71 genome from cerebrospinal fuid of an encephalitis patient by PCR applications. Jpn J Infect Dis. 61:497-9.
47. Girard S, Couderc T, Destombes J, Tiesson D, Delpeyroux F, Blondel B. 1999. Poliovirus induces apoptosis in the mouse central nervous system. J Virol. 73:6066-72. (Pubitemid 29274894)
48. Godman GC, Rifkind RA, Page RB, Howe C, Rose HM. 1964. A Description of Echo-9 Virus Infection in Cultured Cells. Ii. Cytochemical Observations. Am J Pathol. 44:215-45.
49. Hagiwara A, Tagaya I, Komatsu T. 1979. Seroepidemiology of enterovirus 71 among healthy children near Tokyo. Microbiol Immunol. 23:121-4. (Pubitemid 9160447)
50. Hamaguchi T, Fujisawa H, Sakai K, Okino S, Kurosaki N, Nishimura Y, Shimizu H, Yamada M. 2008. Acute encephalitis caused by intrafamilial transmission of enterovirus 71 in adult. Emerg Infect Dis. 14:828-30. (Pubitemid 351838655)
51. Hancil J, Danes L, Maresova V, Hruskova J. 1985. [2 cases of meningeal syndrome, probably caused by enterovirus 71 (EV71)]. Cesk Pediatr. 40:731-3.
52. HASHIMOTO, I, HAGIWARA, A, KODAMA, H. 1978. Neurovirulence in cynomolgus monkeys of enterovirus 71 isolated from a patient with hand, foot and mouth disease. Arch Virol. 56:257-61. (Pubitemid 8303880)
53. Hayward JC, Gillespie SM, Kaplan KM, Packer R, Pallansch M, Plotkin S, Schonberger LB. 1989. Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr Infect Dis J. 8:611-6. (Pubitemid 19227811)
54. He ML, Zheng B, Peng Y, Peiris JS, Poon LL, Yuen KY, Lin MC, Kung HF, Guan Y. 2003. Inhibition of SARS-associated coronavirus infection and replication by RNA interference. JAMA. 290:2665-6. (Pubitemid 37475592)
55. Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T. 2000. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol. 74:4284-90. (Pubitemid 30214436)
56. Ho HY, Cheng ML, Weng S F, Leu YL, Chiu DT. 2009. Antiviral Effect of Epigallocatechin Gallate on Enterovirus 71. J Agric Food Chem.
57. Ho M. 2000. Enterovirus 71: the virus, its infections and outbreaks. J Microbiol Immunol Infect. 33:205-16. (Pubitemid 32046397)
58. Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, Wang JR, Shih SR. 1999. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 341:929-35. (Pubitemid 29441546)
59. Hsueh C, Jung SM, Shih SR, Kuo TT, Shieh WJ, Zaki S, Lin TY, Chang LY, Ning HC, Yen DC. 2000. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofuorescence, and molecular studies. Mod Pathol. 13:1200-5.
60. Hu YC, HSu JT, Huang JH, Ho MS, Ho YC. 2003. Formation of enterovirus-like particle aggregates by recombinant baculoviruses co-expressing P1 and 3CD in insect cells. Biotechnol Lett. 25:919-25. (Pubitemid 36796909)
61. Huang CC. 2001. Neurologic complications of enterovirus 71 infection in children: lessons from this Taiwan epidemic. Acta Paediatr Taiwan. 42:5-7.
62. Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. 1999. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 341:936-42.
63. Huang SC, Chang CL, Wang PS, Tsai Y, Liu HS. 2009a. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J Med Virol. 81:1241-52.
64. Huang SW, Hsu YW, Smith DJ, Kiang D, Tsai HP, Lin KH, Wang SM, Liu CC, Su IJ, Wang JR. 2009b. Reemergence of enterovirus 71 in 2008 in taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol. 47:3653-62.
65. Huang YP, Lin TL, Kuo CY, Lin MW, Yao CY, Liao HW, Hsu LC, Yang CF, Yang JY, Chen PJ, Wu HS. 2008. The circulation of subgenogroups B5 and C5 of enterovirus 71 in Taiwan from 2006 to 2007. Virus Res. 137:206-12.
66. Iwai M, Masaki A, Hasegawa S, Obara M, Horimoto E, Nakamura K, Tanaka Y, Endo K, Tanaka K, Ueda J, Shiraki K, Kurata T, Takizawa T. 2009. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis. 62:254-9.
67. Jackson RJ, Hunt SL, Gibbs CL, Kaminski A. 1994. Internal initiation of translation of picornavirus RNAs. Mol Biol Rep. 19:147-59.
68. Jackson WT, Giddings Jr TH, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, Kirkegaard K. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3:e156.
69. Jaks E, Gavutis M, Uze G, Martal J, Piehler J. 2007. Diferential receptor subunit afnities of type I interferons govern diferential signal activation. J Mol Biol. 366:525-39. (Pubitemid 46136210)
70. Jee YM, Cheon DS, Kim K, Cho JH, Chung YS, Lee J, Lee SH, Park KS, Lee JH, Kim EC, Chung HJ, Kim DS, Yoon JD, Cho HW. 2003. Genetic analysis of the VP1 region of human enterovirus 71 strains isolated in Korea during 2000. Arch Virol. 148:1735-46. (Pubitemid 37144177)
71. Jezequel AM, Steiner JW. 1966. Some ultrastructural and histochemical aspects of Coxsackie virus-cell interactions. Lab Invest. 15:1055-83.
72. Ke GM, Lin KH, Lu PL, Tung YC, Wang CF, Ke LY, Lee MS, Lin PC, Su HJ, Lin YY, Huang TP, Wang JR, Wang SY, Hsu LC, Chu PY. 2011. Molecular epidemiology of Echovirus 30 in Taiwan, 1988-2008.
73. Virus Genes. Kehle J, Roth B, Metzger C, Pftzner A, Enders G. 2003. Molecular characterization of an Enterovirus 71 causing neurological disease in Germany. J Neurovirol. 9:126-8. (Pubitemid 36372552)
74. Komatsu H, Shimizu Y, Takeuchi Y, Ishiko H, Takada H. 1999. Outbreak of severe neurologic involvement associated with Enterovirus 71 infection. Pediatr Neurol. 20:17-23. (Pubitemid 29056499)
75. Konishi E, Yamaoka M, Kurane I, Mason PW. 2000. A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice. Vaccine. 18:1133-9.
76. Kuo CJ, Shie JJ, Fang JM, Yen GR, Hsu JT, Liu HG, Tseng SN, Chang SC, Lee CY, Shih SR, Liang PH. 2008. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents. Bioorg Med Chem. 16:7388-98.
77. Kuo KK, Chang JS, Wang KC, Chiang LC. 2009. Water Extract of Glycyrrhiza uralensis Inhibited Enterovirus 71 in a Human Foreskin Fibroblast Cell Line. Am J Chin Med. 37:383-94.
78. Kuo RL, Kung SH, Hsu YY, Liu WT. 2002. Infection with enterovirus 71 or expression of its 2A protease induces apoptotic cell death. J Gen Virol. 83:1367-76.
79. Lee TC, Guo HR, Su HJ, Yang YC, Chang HL, Chen KT. 2009. Diseases caused by enterovirus 71 infection. Pediatr Infect Dis J. 28:904-10.
80. Lee YR, Lei HY, Liu MT, Wang JR, Chen SH, Jiang-Shieh YF, Lin YS, Yeh TM, Liu CC, Liu HS. 2008. Autophagic machinery activated by dengue virus enhances virus replication. Virology. 374:240-8.
81. Li CC, Yang MY, Chen RF, Lin TY, Tsao KC, Ning HC, Liu HC, Lin SF, Yeh WT, Chu YT, Yang KD. 2002a. Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan. Scand J Infect Dis. 34:104-9. (Pubitemid 34213370)
82. Li ML, Hsu TA, Chen TC, Chang SC, Lee JC, Chen CC, Stollar V, Shih SR. 2002b. The 3C protease activity of enterovirus 71 induces human neural cell apoptosis. Virology. 293:386-95.
83. Li X, Bangari DS, Sharma A, Mittal SK. 2009. Bovine adenovirus serotype 3 utilizes sialic acid as a cellular receptor for virus entry. Virology. 392:162-8.
84. Li ZH, Li CM, Ling P, Shen FH, Chen SH, Liu CC, Yu CK. 2008. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis. 197:854-7. (Pubitemid 351417008)
85. Liang CC, Sun MJ, Lei HY, Chen SH, Yu CK, Liu CC, Wang JR, Yeh TM. 2004. Human endothelial cell activation and apoptosis induced by enterovirus 71 infection. J Med Virol. 74:597-603.
86. Lin CW, Wu CF, Hsiao NW, Chang CY, Li SW, Wan L, Lin YJ, Lin WY. 2008a. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents. 32:355-9.
87. Lin JY, Li ML, Huang PN, Chien KY, Horng JT, Shih SR. 2008b. Heterogeneous nuclear ribonuclear protein K interacts with the enterovirus 71 5' untranslated region and participates in virus replication. J Gen Virol. 89:2540-9.
88. Lin JY, Li ML, Shih SR. 2009a. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 37:47-59.
89. Lin JY, Shih SR, Pan M, Li C, Lue CF, Stollar V, Li ML. 2009b. hnRNP A1 interacts with the 5' untranslated regions of enterovirus 71 and Sindbis virus RNA and is required for viral replication. J Virol. 83:6106-14.
90. Lin KH, Hwang KP, Ke GM, Wang CF, KE LY, Hsu YT, Tung YC, Chu PY, Chen BH, Chen HL, Kao CL, Wang JR, Eng HL, Wang SY, Hsu LC, Chen HY. 2006. Evolution of EV71 genogroup in Taiwan from 1998 to 2005: an emerging of subgenogroup C4 of EV71. J Med Virol. 78:254-62.
91. Lin TY, Chang LY, Huang YC, Hsu KH, Chiu CH, Yang KD. 2002a. Diferent proinfammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 91:632-5.
92. LiN TY, HSIA SH, Huang YC, Wu CT, Chang LY. 2003. Proinfammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin Infect Dis. 36:269-74.
93. Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, Horng JT. 2009c. Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and infammation activities. Am J Chin Med. 37:143-58.
94. Lin YC, Wu CN, Shih SR, Ho MS. 2002b. Characterization of a Vero cell-adapted virulent strain of enterovirus 71 suitable for use as a vaccine candidate. Vaccine. 20:2485-93.
95. Lin YL, Chen LK, Liao CL, Yeh CT, Ma SH, Chen JL, Huang YL, Chen SS, Chiang HY. 1998. DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol. 72:191-200.
96. Lin YW, Wang SW, TUNG YY, Chen SH. 2009d. Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood). 234:1166-73.
97. Liu CC, Tseng HW, Wang SM, Wang JR, Su IJ. 2000. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J Clin Virol. 17:23-30.
98. Liu J, Wei T, Kwang J. 2002. Avian encephalomyelitis virus induces apoptosis via major structural protein VP3. Virology. 300:39-49.
99. Liu ML, Lee YP, Wang YF, Lei HY, Liu CC, Wang SM, Su IJ, Wang JR, Yeh TM, Chen SH, Yu CK. 2005. Type I interferons protect mice against enterovirus 71 infection. J Gen Virol. 86:3263-9.
100. Lum LC, Wong KT, Lam SK, Chua KB, Goh AY, Lim WL, Ong BB, Paul G, Abubakar S, Lambert M. 1998. Fatal enterovirus 71 encephalomyelitis. J Pediatr. 133:795-8. (Pubitemid 28563953)
101. Marissen WE, Lloyd RE. 1998. Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells. Mol Cell Biol. 18:7565-74. (Pubitemid 28533075)
102. Mcminn P, Lindsay K, Perera D, Chan HM, Chan KP, Cardosa MJ. 2001a. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol. 75:7732-8. (Pubitemid 32738033)
103. Mcminn P, Stratov I, Nagarajan L, Davis S. 2001b. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 32:236-42. (Pubitemid 32524793)
104. McMinn PC. 2002. An overview of the evolution of enterovirus 71 and its clinical and public health signifcance. FEMS Microbiol Rev. 26:91-107. (Pubitemid 34454778)
105. Miwa C, Ohtani M, Watanabe H, Fujimoto J, Kinbara K, Tanaka H. 1980. Epidemic of hand, foot and mouth disease in Gifu Prefecture in 1978. Jpn J Med Sci Biol. 33:167-80. (Pubitemid 10030866)
106. Mizuta K, Abiko C, Murata T, Matsuzaki Y, Itagaki T, Sanjoh K, Sakamoto M, Hongo S, Murayama S, Hayasaka K. 2005. Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003. J Clin Microbiol. 43:6171-5. (Pubitemid 43100685)
107. Morley SJ, Curtis PS, Pain VM. 1997. eIF4G: translation's mystery factor begins to yield its secrets. RNA. 3:1085-104. (Pubitemid 27424277)
108. Mulders MN, Salminen M, Kalkkinen N, Hovi T. 2000. Molecular epidemiology of coxsackievirus B4 and disclosure of the correct VP1/2A(pro) cleavage site: evidence for high genomic diversity and long-term endemicity of distinct genotypes. J Gen Virol. 81:803-12. (Pubitemid 30105511)
109. Nasri D, Bouslama L, Pillet S, Bourlet T, Aouni M, Pozzetto B. 2007. Basic rationale, current methods and future directions for molecular typing of human enterovirus. Expert Rev Mol Diagn. 7:419-34. (Pubitemid 47066556)
110. Nichol KL. 2003. The efcacy, efectiveness and cost-efectiveness of inactivated infuenza virus vaccines. Vaccine. 21:1769-75. (Pubitemid 36398371)
111. Nilsson EC, Jamshidi F, Johansson SM, Oberste MS, Arnberg N. 2008. Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol. 82:3061-8. (Pubitemid 351329194)
112. Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med.
113. Nishimura Y, Wakita T, Shimizu H. 2010. Tyrosine sulfation of the amino terminus of PSGL-1 is critical for enterovirus 71 infection. PLoS Pathog. 6:e1001174.
114. Nolan MA, Craig ME, Lahra MM, Rawlinson WD, Prager PC, Williams GD, Bye AM, Andrews PI. 2003. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology. 60:1651-6. (Pubitemid 36618093)
115. Ong KC, Devi S, Cardosa MJ, Wong KT. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 84:661-5.
116. Ooi MH, Wong SC, Mohan A, Podin Y, Perera D, Clear D, Del Sel S, Chieng CH, Tio PH, Cardosa MJ, Solomon T. 2009. Identifcation and validation of clinical predictors for the risk of neurological involvement in children with hand, foot, and mouth disease in Sarawak. BMC Infect Dis. 9:3.
117. Ooi MH, Wong SC, Podin Y, Akin W, Del Sel S, Mohan A, Chieng CH, Perera D, Clear D, Wong D, Blake E, Cardosa J, Solomon T. 2007. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 44:646-56.
118. Patel KP, Bergelson JM. 2009. Receptors identifed for hand, foot and mouth virus. Nat Med. 15:728-9.
119. Pevear DC, Tull TM, Seipel ME, Groarke JM. 1999. Activity of pleconaril against enteroviruses. Antimicrob Agents Chemother. 43:2109-15. (Pubitemid 29421185)
120. Podin Y, Gias EL, Ong F, Leong YW, Yee SF, Yusof MA, Perera D, Teo B, Wee TY, Yao SC, Yao SK, Kiyu A, Arif MT, Cardosa MJ. 2006. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the frst 7 years. BMC Public Health. 6:180.
121. QU, M, Li, J, JIA, L, Tan, X. J, Gao, Z. Y, Yan, H. Q, GUO, J, Li, X. T, Li, X. Y, Wang, Q. Y, Xu, W. B, Huang, F. 2011. [Etiology of hand-foot-and-mouth disease and genetic characteristics of Coxsackievirus A16 in Beijing, 2009]. Bing Du Xue Bao. 26:432-6.
122. Raha AR, Varma NR, Yusof K, Ross E, Foo HL. 2005. Cell surface display system for Lactococcus lactis: a novel development for oral vaccine. Appl Microbiol Biotechnol. 68:75-81. (Pubitemid 41202117)
123. Roberts LO, Boxall AJ, Lewis LJ, Belsham GJ, Kass GE. 2000. Caspases are not involved in the cleavage of translation initiation factor eIF4GI during picornavirus infection. J Gen Virol. 81:1703-7. (Pubitemid 30427075)
124. Rogers JM, Diana GD, Mckinlay MA. 1999. Pleconaril. A broad spectrum antipicornaviral agent. Adv Exp Med Biol. 458:69-76.
125. Romero JR. 2001. Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs. 10:369-79. (Pubitemid 32117944)
126. Rossmann MG, He Y, Kuhn RJ. 2002. Picornavirus-receptor interactions. Trends Microbiol. 10:324-31. (Pubitemid 34756532)
127. Rubio N, Martin-Clemente B, Lipton HL. 2003. High-neurovirulence GDVII virus induces apoptosis in murine astrocytes through tumor necrosis factor (TNF)-receptor and TNF-related apoptosis-inducing ligand. Virology. 311:366-75. (Pubitemid 36808777)
128. Sabin AB. 1981. Paralytic poliomyelitis: Old dogmas and new perspectives. Rev Infect Dis. 3:543-64.
129. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral efectors. Nat Rev Immunol. 8:559-68.
130. Samuda GM, Chang WK, Yeung CY, Tang PS. 1987. Monoplegia caused by Enterovirus 71: an outbreak in Hong Kong. Pediatr Infect Dis J. 6:206-8. (Pubitemid 17116144)
131. Sanders SA, Herrero LJ, Mcphie K, Chow SS, Craig ME, Dwyer DE, Rawlinson W, Mcminn PC. 2006. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol. 151:1003-13.
132. Schlegel A, Giddings Jr TH, Ladinsky MS, Kirkegaard K. 1996. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol. 70:6576-88. (Pubitemid 26307362)
133. Schmid D, Munz C. 2007. Innate and adaptive immunity through autophagy. Immunity. 27:11-21. (Pubitemid 47089030)
134. Schmidt NJ, Lennette EH, Ho HH. 1974. An apparently new enterovirus isolated from patients with disease of the central nervous system. J Infect Dis. 129:304-9.
135. Schnabl KL, Field C, Clandinin MT. 2009. Ganglioside composition of diferentiated Caco-2 cells resembles human colostrum and neonatal rat intestine. Br J Nutr. 101:694-700.
136. Shen WC, Chiu HH, Chow KC, Tsai CH. 1999. MR imaging fndings of enteroviral encephaloymelitis: an outbreak in Taiwan. AJNR Am J Neuroradiol. 20:1889-95.
137. Shieh WJ, Jung SM, Hsueh C, Kuo TT, Mounts A, Parashar U, Yang CF, Guarner J, Ksiazek TG, Dawson J, Goldsmith C, Chang GJ, Oberste SM, Pallansch MA, Anderson LJ, Zaki SR. 2001. Pathologic studies of fatal cases in outbreak of hand, foot, and mouth disease, Taiwan. Emerg Infect Dis. 7:146-8. (Pubitemid 32173346)
138. Shih SR, Ho MS, Lin KH, Wu SL, Chen YT, Wu CN, Lin TY, Chang LY, Tsao KC, Ning HC, Chang PY, Jung SM, Hsueh C, Chang KS. 2000. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan, 1998. Virus Res. 68:127-36. (Pubitemid 30665534)
139. Shimizu H, Utama A, Onnimala N, Li C, Li-Bi Z, Yu-Jie M, Pongsuwanna Y, Miyamura T. 2004. Molecular epidemiology of enterovirus 71 infection in the Western Pacifc Region. Pediatr Int. 46:231-5. (Pubitemid 38526625)
140. Shimizu H, Utama A, Yoshii K, Yoshida H, Yoneyama T, Sinniah M, Yusof Ma, Okuno Y, Okabe N, Shih SR, Chen HY, Wang GR, Kao CL, Chang KS, Miyamura T, Hagiwara A. 1999. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn J Infect Dis. 52:12-5. (Pubitemid 29414613)
141. Singh S, Chow VT, Chan KP, Ling AE, Poh CL. 2000. RT-PCR, nucleotide, amino acid and phylogenetic analyses of enterovirus type 71 strains from Asia. J Virol Methods. 88:193-204.
142. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, Mcminn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 10:778-90.
143. Su FM, Chang JS, Wang KC, Tsai JJ, Chiang LC. 2008. A Water extract of Pueraria lobata inhibited cytotoxicity of enterovirus 71 in a human foreskin fbroblast cell line. Kaohsiung J Med Sci. 24:523-30.
144. Tagaya I, Tachibana K. 1975. Epidemic of hand, foot and mouth disease in Japan, 1972-1973: diference in epidemiologic and virologic features from the previous one. Jpn J Med Sci Biol. 28:231-4.
145. Taylor MP, Kirkegaard K. 2008. Potential subversion of autophagosomal pathway by picornaviruses. Autophagy. 4:286-9. (Pubitemid 351458088)
146. Teng Z, Tan XJ, Shao JJ, Zhang Y, Kuang XZ, Zhang X, Xu WB. 2011. [Epidemiology and etiology of hand-foot-and-mouth disease in Shanghai, 2009]. Bing Du Xue Bao. 26:437-42.
147. Teodoro JG, Branton PE. 1997. Regulation of apoptosis by viral gene products. J Virol. 71:1739-46. (Pubitemid 27078549)
148. Tolskaya EA, Romanova LI, Kolesnikova MS, Ivannikova TA, Smirnova EA, Raikhlin NT, Agol VI. 1995. Apoptosis-inducing and apoptosis-preventing functions of poliovirus. J Virol. 69:1181-9.
149. Tsunoda I, Kurtz CI, Fujinami RS. 1997. Apoptosis in acute and chronic central nervous system disease induced by Teiler's murine encephalomyelitis virus. Virology. 228:388-93. (Pubitemid 27238807)
150. Tu PV, Tao NT, Perera D, Huu TK, Tien NT, Tuong TC, How OM, Cardosa MJ, Mcminn PC. 2007. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 13:1733-41. (Pubitemid 350126202)
151. Tucker SP, Tornton CL, Wimmer E, Compans RW. 1993. Vectorial release of poliovirus from polarized human intestinal epithelial cells. J Virol. 67:4274-82. (Pubitemid 23180754)
152. Tung WS, Bakar SA, Sekawi Z, Rosli R. 2007. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ter. 5:6.
153. Van Der Sanden S, Koopmans M, Uslu G, Van Der Avoort H. 2009. Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008. J Clin Microbiol. 47:2826-33.
154. Varki NM, Varki A. 2007. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest. 87:851-7. (Pubitemid 47267816)
155. Wang SM, Lei HY, Huang KJ, Wu JM, Wang JR, Yu CK, Su IJ, Liu CC. 2003. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J Infect Dis. 188:564-70.
156. Wang SM, LEI HY, Yu CK, Wang JR, Su IJ, Liu CC. 2008. Acute chemokine response in the blood and cerebrospinal fuid of children with enterovirus 71-associated brainstem encephalitis. J Infect Dis. 198:1002-6.
157. Wang SM, Liu CC, Tseng HW, Wang JR, Huang CC, Chen YJ, Yang YJ, Lin SJ, Yeh TF. 1999. Clinical spectrum of enterovirus 71 infection in children in southern Taiwan, with an emphasis on neurological complications. Clin Infect Dis. 29:184-90.
158. Weng KF, Chen LL, Huang PN, Shih SR. 2010. Neural pathogenesis of enterovirus 71 infection. Microbes Infect. 12:505-10.
159. Wong WR, Chen YY, Yang SM, Chen YL, Horng JT. 2005. Phosphorylation of PI3K/Akt and MAPK/ERK in an early entry step of enterovirus 71. Life Sci. 78:82-90.
160. Wu CN, Lin YC, Fann C, Liao NS, Shih SR, Ho MS. 2001. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 20:895-904. (Pubitemid 34015831)
161. Wu Y, Lou Z, Miao Y, Yu Y, Dong H, Peng W, Bartlam M, Li X, Rao Z. 2010. Structures of EV71 RNA-dependent RNA polymerase in complex with substrate and analogue provide a drug target against the hand-foot-and-mouth disease pandemic in China. Protein Cell. 1:491-500.
162. Yamayoshi S, Koike S. 2011. Identifcation of the Human SCARB2 Region Tat Is Important for Enterovirus 71 Binding and Infection.
163. J Virol. Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med.
164. Yan JJ, Wang JR, Liu CC, Yang HB, Su IJ. 2000. An outbreak of enterovirus 71 infection in Taiwan 1998: a comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J Clin Virol. 17:13-22.
165. Yang B, Chuang H, Yang KD. 2009. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 6:141.
166. Yi L, He Y, Chen Y, Kung HF, He ML. 2011. Potent inhibition of human enterovirus 71 replication by type I interferon subtypes. Antivir Ter. 16:51-8.
167. Yu H, Chen W, Chang H, Tang R, Zhao J, Gan L, Liu B, Chen J, Wang M. 2010. Genetic analysis of the VP1 region of enterovirus 71 reveals the emergence of genotype A in central China in 2008. Virus Genes. 41:1-4.
168. Zhang Y, Tan XJ, Wang HY, Yan DM, Zhu SL, Wang DY, Ji F, Wang XJ, Gao YJ, Chen L, An HQ, Li DX, Wang SW, Xu AQ, Wang ZJ, Xu WB. 2009. An outbreak of hand, foot, and mouth disease associated with subgenotype C4 of human enterovirus 71 in Shandong, China. J Clin Virol. 44:262-7.
169. Zhu JP, Xu ZG, Chen H, Zhang X, Fan DY, Wang J. 2009. [Primary detection of pathogen from children with hand, foot, and mouth disease in Beijing, 2007]. Bing Du Xue Bao. 25:23-8.